| Drug Name: | Tafamidis (594839-88-0) |
|---|---|
| PubChem ID: | 11001318 |
| SMILES: | C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl |
| InchiKey: | TXEIIPDJKFWEEC-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 308.12 |
| LogP | : | 4.4998 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 63.33 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Abdominal Pain | PROTECT |
| Diarrhoea | PROTECT |
| Urinary Tract Infection | PROTECT |
| Vaginal Infection | PROTECT |